A Phase 3, Long-Term Active Treatment Extension Study Of Mongersen (GED-0301) In Subjects With Crohns Disease
Principal Investigator(s)
Email for information
Funded by
GENEVA
Research Start Date
Status
Active
This study will evaluate the long-term safety and efficacy of oral GED-0301 in subjects with Chron's Disease.
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.